ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ORGO Organogenesis Holdings Inc

2.74
-0.11 (-3.86%)
17 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Organogenesis Holdings Inc ORGO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.11 -3.86% 2.74 15:13:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.86 2.69 2.86 2.74 2.85
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202415:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:05GLOBEOrganogenesis Holdings Inc. Reports First Quarter 2024..
02/5/202406:00GLOBEOrganogenesis Achieves Primary Endpoint in Phase 3 Clinical..
16/4/202406:30GLOBEOrganogenesis Holdings Inc. to Report First Quarter of..
03/4/202406:30GLOBEOrganogenesis Announces Favorable Court Ruling Dismissing..
29/2/202415:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202415:05EDGAR2Form 8-K - Current report
29/2/202415:05GLOBEOrganogenesis Holdings Inc. Reports Fourth Quarter 2023 and..
23/2/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202406:30GLOBEOrganogenesis Holdings Inc. to Participate in the BTIG..
08/2/202415:05GLOBEOrganogenesis Holdings Inc. to Report Fourth Quarter and..
02/2/202408:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202415:43EDGAR2Form 144 - Report of proposed sale of securities
09/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:10EDGAR2Form 8-K - Current report
09/11/202315:05GLOBEOrganogenesis Holdings Inc. Reports Third Quarter 2023..
05/10/202306:30GLOBEOrganogenesis Holdings Inc. to Report Third Quarter of..
28/9/202308:15GLOBEOrganogenesis Applauds Withdrawal of Local Coverage..
06/9/202315:05GLOBEOrganogenesis Holdings Inc. to Participate in the Morgan..
09/8/202315:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:23EDGAR2Form 8-K - Current report
09/8/202315:05GLOBEOrganogenesis Holdings Inc. Reports Second Quarter 2023..
10/7/202306:30GLOBEOrganogenesis Holdings Inc. to Report Second Quarter of..